Search

everythinglearnresearchcommunity

for

Search:↓

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Antiandrogen therapy is effective and well tolerated for treating women's androgenic disorders like hirsutism, acne, and hair loss.

Testosterone therapy can help postmenopausal women with low sexual desire if monitored carefully.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Hormonal therapy is a good option for women with severe acne, especially when there's a chance of hormone imbalance.

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

Sex hormone therapy is effective for certain skin conditions like acne and seborrhea, but less so for female hair loss and excessive hair growth.

Testosterone in older women can increase bone density, muscle mass, fat mass, improve memory, and boost libido, but may cause nipple color changes.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Testosterone therapy can improve skin and hair in men with low testosterone but may cause skin irritation with certain treatments.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Certain hormone medications can treat symptoms like acne and unwanted hair, regulate periods, and prevent pregnancy in women and teenage girls.

Goserelin injections can effectively manage hyperandrogenism symptoms in postmenopausal women who can't have surgery.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

A postmenopausal woman's facial redness, acne, and excess hair were caused by too much hormone therapy for insomnia, but improved after stopping the treatment.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Transgender patients with hair loss need personalized treatment plans considering their unique needs.

A man developed hair loss from testosterone treatment but improved with additional medication.

Hormonal therapy is becoming a promising treatment for acne.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

Testosterone replacement is recommended for men with low testosterone levels and symptoms of hypogonadism.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Hormonal therapies can improve skin issues by adjusting hormone levels, with future advancements promising better results.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

The case showed the need for quick investigation of virilization in women and how emotional health is linked to physical health.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.